Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Neurogene (NGNE) Other Non Operating Income (2018 - 2025)

Neurogene (NGNE) has disclosed Other Non Operating Income for 5 consecutive years, with $149000.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non Operating Income rose 4.2% year-over-year to $149000.0, compared with a TTM value of $1.7 million through Sep 2025, up 271.46%, and an annual FY2024 reading of $574000.0, down 96.49% over the prior year.
  • Other Non Operating Income was $149000.0 for Q3 2025 at Neurogene, down from $1.2 million in the prior quarter.
  • Across five years, Other Non Operating Income topped out at $1.2 million in Q2 2025 and bottomed at $143000.0 in Q1 2024.